Literature DB >> 10925303

TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase.

P Dri1, C Gasparini, R Menegazzi, R Cramer, L Albéri, G Presani, S Garbisa, P Patriarca.   

Abstract

A down-modulation of both the 55-kDa (TNF-R55) and the 75-kDa (TNF-R75) TNF receptors is observed in neutrophils exposed to a variety of stimuli. Proteolytic cleavage of the extracellular region of both receptors (shedding) and, with TNF, internalization of TNF-R55 and shedding of TNF-R75 are the proposed mechanisms. We have characterized the TNF-induced shedding of TNF receptors in neutrophils and determined the nature of the involved proteinase. Neutrophils exposed to TNF release both TNF receptors. A release of TNF receptors comparable to that observed with TNF was induced with TNF-R55-specific reagents (mAbs and a mutant of TNF) but not with the corresponding TNF-R75-specific reagents. A hydroxamic acid compound (KB8301) almost completely inhibited shedding of TNF-R55 and to a lesser degree shedding of TNF-R75. KB8301 also inhibited FMLP-induced shedding to a similar extent. Shedding was also inhibited by 1,10-phenanthroline, but this effect was considered nonspecific as the compound, at variance with KB8301, almost completely inhibited TNF and FMLP-induced PMN activation. Diisopropylfluorophosphate partially inhibited shedding of TNF-R75, suggesting the contribution of a serine proteinase to the release of this receptor. Shedding activity was not affected by matrix metalloproteinases inhibitors nor was it released in the supernatants of FMLP-stimulated neutrophils. These results suggest that TNF induces release of its receptors, that such a release is mediated via TNF-R55, and that a membrane-bound and non-matrix metalloproteinase is involved in the process. The possibility that ADAM-17, which we show to be expressed in neutrophils, might be the involved proteinase is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925303     DOI: 10.4049/jimmunol.165.4.2165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.

Authors:  Anthony D Dorr; Michael R Wilson; Kenji Wakabayashi; Alicia C Waite; Brijesh V Patel; Nico van Rooijen; Kieran P O'Dea; Masao Takata
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

2.  Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels.

Authors:  David J Rowlands; Mohammad Naimul Islam; Shonit R Das; Alice Huertas; Sadiqa K Quadri; Keisuke Horiuchi; Nilufar Inamdar; Memet T Emin; Jens Lindert; Vadim S Ten; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

3.  Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.

Authors:  Elke Kunisch; Muktheshwar Gandesiri; Reneé Fuhrmann; Andreas Roth; Rando Winter; Raimund W Kinne
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

4.  Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.

Authors:  Cécile Contin; Vincent Pitard; Yahsou Delmas; Nadège Pelletier; Thierry Defrance; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

5.  Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice.

Authors:  Szabolcs Bertok; Michael R Wilson; Anthony D Dorr; Justina O Dokpesi; Kieran P O'Dea; Nandor Marczin; Masao Takata
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

6.  Pharmacological analysis for mechanisms of GPI-80 release from tumour necrosis factor-alpha-stimulated human neutrophils.

Authors:  Takeaki Nitto; Yoshihiko Araki; Yuji Takeda; Fujiro Sendo
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling.

Authors:  Britney L Moss; Shimon Gross; Seth T Gammon; Anant Vinjamoori; David Piwnica-Worms
Journal:  J Biol Chem       Date:  2008-01-17       Impact factor: 5.157

8.  Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier.

Authors:  Mohammed F Shamji; Liufang Jing; Jun Chen; Priscilla Hwang; Odelia Ghodsizadeh; Allan H Friedman; William J Richardson; Lori A Setton
Journal:  J Neurosurg Spine       Date:  2008-08

9.  Regulation of the receptor for TNFalpha, TNFR1, in human conjunctival epithelial cells.

Authors:  Ellen B Cook; James L Stahl; Frank M Graziano; Neal P Barney
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

10.  sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica.

Authors:  Magda K Ellis; Yuesheng Li; Xunya Hou; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2007-10-12       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.